Scholar

Pablo Pelegrı́n

H-index: 62
Biology 65%
Medicine 26%
ppelegrin.bsky.social
Looking for passionate candidate to apply to PhD fellowship to University of Murcia call:

www.um.es/documents/d/...

Interested students contact me!
www.um.es

Reposted by: Pablo Pelegrı́n

jem.org
Cheng, Qiu et al @jhu.edu provide new insights into the molecular mechanism of #phagosome maturation and the dynamics of host defense response following phagosome-mediated bacterial degradation in peritoneal #macrophages. rupress.org/jem/article/...

#InnateImmunity #inflammation #InfectiousDisease

Reposted by: Pablo Pelegrı́n

jem.org
#NLRP3 is a target for antiinflammatory therapies & can be inhibited by the tool compound MCC950. Wilhelmsen, @colllab.bsky.social et al characterize new small-molecule inhibitors, BAL-0028 & BAL-0598, that have a distinct mechanism of action & binding site. rupress.org/jem/article/...
#Inflammasome

Reposted by: Pablo Pelegrı́n

lozanzi.bsky.social
#InterferonPower! Thrilled for our latest work @cp-cell.bsky.social! With @danielboehmer.bsky.social, we dug into tons of papers & created what we hope will be a go-to resource for immunologists & non-immunologist about type I, II, III (& IV😉) #interferons! Free👉 authors.elsevier.com/a/1leKGL7PXu...

Reposted by: Pablo Pelegrı́n

labwaggoner.bsky.social
Review @natimmunol.nature.com
The expanding role of the NLRP3 inflammasome from periodic fevers to therapeutic targets
www.nature.com/articles/s41...

Reposted by: Pablo Pelegrı́n

malvinapiz.bsky.social
🚨It’s out @embojournal.org 🚨
Cardiolipin inhibits Caspase-4/11!
Huge thanks to my brilliant supervisors Kate & Pablo, to @s-burgener.bsky.social & Mercedes and all the @inflammasomelab.bsky.social, it was a joy working and laughing with you, and to @brozlab.bsky.social & Si Ming lab.

References

Fields & subjects

Updated 1m